Are plant-based foods the way forward?

February 26, 2021


 

Recently, there has been increased focus on the health implications of excess meat consumption, and the benefits of a plant-based diet. While there is evidence that reducing meat consumption in favor of a plant-based diet is beneficial for human health as well as the environment, the specifics are heavily contested, and as yet there is no definitive evidence on the optimal level of meat consumption or whether red meat is more damaging than white meat.

The overall ‘healthiness’ of a product cannot be boiled down to a single measure. Furthermore, the impact of specific micronutrients varies according to the health status of the individual consumer. This makes evaluating the health implications of ingesting a specific food subjective, and potentially contentious.

A diet high in salt, for instance, is understood to increase blood pressure, which is a significant contributor to cardiovascular disease. As a result, salt and sodium content is also at increased risk of regulation.

Given their high-salt content, this is the most material consideration when analyzing plant-based meat alternatives relative to traditional meat. The comparison is even worse versus plant-based foods such as lentils or tofu. However, when compared to a selected handful of other processed burger products, plant-based versions are actually not any higher in sodium.

The plant-based meat alternatives can also be far higher in saturated fat than other plant-based foods such as lentils, and even higher in saturated fat than animal meats. As with salt, the saturated fat content of plant-based meat alternatives is often similar to that of other processed food products.

There are significant risks of consumer preferences shifting towards healthier product options, as well as the likelihood of further regulation, which may increase operational costs. While the debate around the health impact of plant-based food products is more nuanced, it is clear that, from an environmental perspective, there are benefits from reducing the consumption of animal-based products, which is something consumers are increasingly aware of.

Rebecca White, responsible investment analyst, Newton Investment Management.

All investments involve risk, including the possible loss of principal. Certain investments involve greater or unique risks that should be considered along with the objectives, fees, and expenses before investing.

Charts are provided for illustrative purposes and are not indicative of the past or future performance of any BNY Mellon Investment Management product.

"Newton" and/or the "Newton Investment Management" brand refers to Newton Investment Management Limited. Newton is incorporated in the United Kingdom (Registered in England no. 1371973) and is authorized and regulated by the Financial Conduct Authority in the conduct of investment business. Newton is a subsidiary of The Bank of New York Mellon Corporation. Newton is registered with the SEC in the United States of America as an investment adviser under the Investment Advisers Act of 1940. Newton's investment business is described in Form ADV, Part 1 and 2, which can be obtained from the SEC.gov website or obtained upon request.

BNY Mellon Investment Management is one of the world’s leading investment management organizations and one of the top U.S. wealth managers, encompassing BNY Mellon’s affiliated investment management firms, wealth management organization and global distribution companies. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation and may also be used as a generic term to reference the corporation as a whole or its various subsidiaries generally.

This material has been distributed for informational purposes only. It is educational in nature and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product.

Views expressed are those of the author(s) stated and do not reflect views of the other author or the firm overall. Views are current as of the date of this publication and subject to change. This information contains projections or other forward-looking statements regarding future events, targets or expectations, and is only current as of the date indicated. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Forecasts, estimates and certain information contained herein are based upon proprietary research and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. Certain information contained herein has been obtained from sources believed to be reliable, but not guaranteed. Investors should consult a legal, tax or financial professional in order to determine whether an investment product or service is appropriate for a particular situation. No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. BNY Mellon Securities Corporation is a subsidiary of BNY Mellon.

Not FDIC-Insured | No Bank Guarantee | May Lose Value

MARK-173680-2021-02-24